Method for determination of denatured lipoprotein, reagent for determination of denatured lipoprotein, method for detection of cardiovascular disease, and reagent for detection ofcardiovascular disease
CA 2453538 A1 · Owner: Kyowa Medex Co. Ltd. · Inventors: Masunari, Toshiyuki; Kohno, Hiroaki; Yanagisawa, Takashi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of quantifying a denatured lipoprotein in a biological sample characterized by comprising bringing the biological sample into contact with an antibody against phosphocholine and quantifying the thus formed immune complex; a method of detecting a circulatory disease characterized by comprising bringing a biological sample into contact with an antibody against phosphocholine and quantifying the thus formed immune complex; reagents for quantifying a denatured lipoprotein containing an antibody against phosphocholine; and reagents for detecting a circulatory disease containing an antibody against phosphocholine.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 12, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 12, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 12, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.